In its preliminary proxy, Galena Biopharma (NASDAQ: GALE) said it will seek shareholder approval to effect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE